799012-49-0

Upstream product

• 53386-63-3 1-(2-hydroxyethyl)tetrahydropyrimidin-2(1H)-one 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 799012-66-1 1-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-3-(4-nitrophenyl)-tetrahydro-2(1H)-pyrimidinone 
• 1093656-16-6 1-(2-{[tert-Butyl(diphenyl)silyl]oxy}ethyl)-3-(2-chloro-4-nitrophenyl)tetrahydro-pyrimidin-2(1H)-one 
• 1093656-13-3 1-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-3-(2-methyl-4-nitrophenyl)tetrahydro-pyrimidin-2(1H)-one 
• 1093656-19-9 1-(2-{[tert-Butyl(diphenyl)silyl]oxy}ethyl)-3-[4-nitro-2-(trifluoromethyl)phenyl]tetrahydro-pyrimidin-2(1H)-one 

Relevant academic research and scientific papers

SUBSTITUTED OXAZOLIDINONES AND THEIR USE

The invention relates to novel substituted oxazolidinones, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases, and to the use thereof for producing medicaments for treatment and/or prophylaxis of diseases

Heterocyclic compounds

The present invention relates to the area of blood clotting. The invention relates in particular to certain heterocyclic compounds, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases, and to their use for pro

HETEROCYCLIC COMPOUNDS

The invention concerns blood clotting. The invention particularly concerns certain heterocyclic compounds, methods for the production thereof, their use for treating and/or preventing diseases, and their use for producing medicaments for treating and/or preventing diseases.